tiprankstipranks
HAVN Life Sciences (HAVLF)
OTHER OTC:HAVLF

HAVN Life Sciences (HAVLF) Financial Statements

30 Followers

HAVN Life Sciences Financial Overview

HAVN Life Sciences's market cap is currently ―. The company's EPS TTM is $-2.938; its P/E ratio is >-0.01; HAVN Life Sciences is scheduled to report earnings on September 20, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jan 23Oct 22Jul 22Apr 22Jan 22
Income Statement-
Total RevenueC$ 57.92KC$ 629.49KC$ 67.91KC$ 216.38KC$ 23.02K
Gross ProfitC$ -13.35KC$ 403.66KC$ 22.03KC$ 68.07KC$ 5.86K
EBITC$ -665.73KC$ -4.96MC$ -3.89MC$ -11.35MC$ -2.17M
EBITDAC$ -687.72KC$ -5.00MC$ -3.84MC$ -11.19MC$ -2.04M
Net Income Common StockholdersC$ -665.73KC$ -4.96MC$ -3.90MC$ -11.37MC$ -2.19M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 13.99KC$ 17.26KC$ 112.42KC$ 1.06MC$ 844.86K
Total AssetsC$ 11.11MC$ 3.22MC$ 200.82KC$ 4.06MC$ 13.47M
Total DebtC$ 26.23KC$ 620.00KC$ 561.84KC$ 389.35KC$ 407.05K
Net DebtC$ 12.25KC$ 602.74KC$ 449.43KC$ -666.30KC$ -437.82K
Total LiabilitiesC$ 540.44KC$ 1.35MC$ 1.10MC$ 918.46KC$ 911.37K
Stockholders EquityC$ 837.82KC$ 1.88MC$ -896.15KC$ 3.14MC$ 12.56M
Cash Flow-
Free Cash FlowC$ 1.74MC$ -1.12MC$ -890.50KC$ -1.45MC$ -1.46M
Operating Cash FlowC$ 1.74MC$ -1.12MC$ -890.50KC$ -1.45MC$ -1.45M
Investing Cash Flow--C$ 0.00C$ 28.00KC$ -16.96K
Financing Cash FlowC$ -685.29KC$ 908.52KC$ -52.74KC$ 1.63MC$ -32.74K
Currency in CAD

HAVN Life Sciences Earnings and Revenue History

HAVN Life Sciences Debt to Assets

HAVN Life Sciences Cash Flow

HAVN Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis